Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1918 1
1929 1
1960 1
1961 1
1962 1
1963 2
1967 3
1968 1
1973 1
1977 1
1980 1
1982 1
1984 2
1985 1
1986 2
1987 1
1988 5
1989 3
1990 4
1991 4
1992 6
1993 11
1994 8
1995 9
1996 12
1997 9
1998 7
1999 15
2000 3
2001 9
2002 14
2003 8
2004 21
2005 23
2006 27
2007 25
2008 25
2009 35
2010 34
2011 46
2012 57
2013 51
2014 45
2015 51
2016 34
2017 50
2018 67
2019 94
2020 104
2021 113
2022 128
2023 127
2024 152
2025 157
2026 132

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,588 results

Results by year

Filters applied: . Clear all
Page 1
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial.
Mart MF, Boehm LM, Kiehl AL, Gong MN, Malhotra A, Owens RL, Khan BA, Pisani MA, Schmidt GA, Hite RD, Exline MC, Carson SS, Hough CL, Rock P, Douglas IS, Feinstein DJ, Hyzy RC, Schweickert WD, Bowton DL, Masica A, Orun OM, Raman R, Pun BT, Strength C, Rolfsen ML, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Ely EW, Jackson JC, Girard TD. Mart MF, et al. Among authors: khan ba. Lancet Respir Med. 2024 Aug;12(8):599-607. doi: 10.1016/S2213-2600(24)00077-8. Epub 2024 Apr 30. Lancet Respir Med. 2024. PMID: 38701817 Free PMC article. Clinical Trial.
Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation.
Chaudhary N, Mandal D, Choudhary BS, Patra S, Jain D, Poonia P, Shaikh S, Tekalkar S, Malvankar S, Shivashankar A, Jog E, Pilankar L, Thorat R, Kailje VV, Khanna S, Manna S, Khan BK, Jadhav A, Sharma K, Ramu S, Sahoo S, Jolly MK, Dalal SN, Sinha S, Nair NU, Ruppin E, Lamballe F, Maina F, Verma N. Chaudhary N, et al. Among authors: khan bk. Redox Biol. 2025 Nov;87:103864. doi: 10.1016/j.redox.2025.103864. Epub 2025 Sep 11. Redox Biol. 2025. PMID: 40972157 Free PMC article.
Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions.
Samant S, Bakhos JJ, Wu W, Zhao S, Kassab GS, Khan B, Panagopoulos A, Makadia J, Oguz UM, Banga A, Fayaz M, Glass W, Chiastra C, Burzotta F, LaDisa JF Jr, Iaizzo P, Murasato Y, Dubini G, Migliavacca F, Mickley T, Bicek A, Fontana J, West NEJ, Mortier P, Boyers PJ, Gold JP, Anderson DR, Tcheng JE, Windle JR, Samady H, Jaffer FA, Desai NR, Lansky A, Mena-Hurtado C, Abbott D, Brilakis ES, Lassen JF, Louvard Y, Stankovic G, Serruys PW, Velazquez E, Elias P, Bhatt DL, Dangas G, Chatzizisis YS. Samant S, et al. Among authors: khan b. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2479-2497. doi: 10.1016/j.jcin.2023.07.022. JACC Cardiovasc Interv. 2023. PMID: 37879802 Free article. Review.
Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functions.
Boucher A, Anderson C, Hinman R, Kindschuh M, Fung J, Wang T, Klooster I, Kim E, Roth C, Vander Oever M, Khan B, Zelikson N, Vagima Y, Saribasak H, Santry L, Klapper LN, Hess S, Mooney J, Bublik DR, Laken H, Barzel A, Borden P, Plewa C, Chadbourne AM, Bridgen D, Nahmad AD. Boucher A, et al. Among authors: khan b. Front Immunol. 2025 Jul 30;16:1621222. doi: 10.3389/fimmu.2025.1621222. eCollection 2025. Front Immunol. 2025. PMID: 40808959 Free PMC article.
Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer.
Jog E, Jainarayanan AK, La Ferlita A, Chakraborty A, Dalwai A, Yahya S, Shivashankar A, Choudhary BS, Chandramouli A, Kazi M, Jain D, Khapare N, B A, Khan BK, Gera P, Patil P, Thorat R, Verma N, Sehgal L, Saklani A, Kamat SS, Dalal SN, Chaudhary N. Jog E, et al. Among authors: khan bk. Redox Biol. 2025 Feb;79:103458. doi: 10.1016/j.redox.2024.103458. Epub 2024 Dec 11. Redox Biol. 2025. PMID: 39705849 Free PMC article.
1,588 results